Abstract:Genome-wide association studies (GWAS) and corresponding transcriptomics research have been leveraged to identify disease risk variants in hematological disorders with the hopes of developing more personalized treatment regimens. Interestingly, >90% of GWAS-identified variants are found in non-coding regions of the genome, indicating they likely affect the regulatory machinery that governs chromatin structure. Non-coding elements, such as enhancers, play important roles in supporting chromatin mechanisms, including cell-type specific gene expression, cell fates and disease states. However, these variants are difficult to study compared to protein-coding mutations and have been challenging to directly associate with phenotypic readouts. To date, efforts to understand the effects of non-coding variants on chromatin dynamics have been focused on chromatin accessibility (ATAC-seq) and DNA methylation profiling. Notably, these assays can only provide a binary, “open-or-closed,” view of chromatin and often fail to provide mechanistic insight into disease etiology. Epigenomic features - such as histone post-translational modifications (PTMs) and chromatin-associated proteins - mark distinct genomic compartments (e.g., promoters, enhancers) and regulate chromatin structure, gene expression, and cell function. Mapping these features provides a rich context to study cell fate and has great potential for discovering new biomarkers and drug targets. Despite this, efforts to integrate epigenomics into large scale lymphatic and myeloid research have been hampered by the poor sensitivity, high background, and low throughput of traditional chromatin mapping technology (i.e., ChIP-seq). Here, we present autoCUT&RUN, a high throughput assay for rapid, ultra-sensitive profiling of epigenomic features from FACS-isolated primary cells or tissues. This workflow generates reliable profiles from <10,000 cells per reaction, and is supported by a rigorous optimization strategy, high-quality antibodies, and quantitative spike-in controls. As part of a multi-site collaboration with the Immunological Genome Consortium, we used our autoCUT&RUN platform to build a comprehensive epigenomic database of mouse immune cells - composed of >1,500 epigenomic profiles from >100 different FACS-isolated primary immune cell types. These studies set the stage to leverage high-throughput epigenomics for multi-site clinical studies to identify and/or characterize novel biomarkers for precision medicine applications. Further, we will discuss our integration of CUT&RUN and Enzymatic Methylation-sequencing (CUT&RUN-EM) to deliver a true multiomic view of the co-occurrence of epigenomic features and DNA methylation, which can reveal multivalent cellular mechanisms and deconvolute sample heterogeneity.

Integrated epigenomic exposure signature discovery

Identifying immune signatures of common exposures through co-occurrence of T-cell receptors in tens of thousands of donors

Childhood exposure to non-persistent endocrine disrupting chemicals and multi-omic profiles: A panel study

Estimating Exposome Score for Schizophrenia Using Predictive Modeling Approach in Two Independent Samples: The Results From the EUGEI Study

Open Application of Statistical and Machine Learning Models to Explore the Impact of Environmental Exposures on Health and Disease: An Asthma Use Case

State-of-the-art methods for exposure-health studies: Results from the exposome data challenge event

Precision environmental health monitoring by longitudinal exposome and multi-omics profiling

Abstract P17: Epigenomic fingerprinting of limited primary immune cells using automated CUT&RUN

Gene expression signatures that predict radiation exposure in mice and humans

DeepEXPOKE: A Deep Learning Framework with Polygenic Risk Scores as Knockoffs for Deconvoluting Genetic and Non-Genetic Exposure Risks in Sepsis and Coronary Heart Disease

A machine-learning exploration of the exposome from preconception in early childhood atopic eczema, rhinitis and wheeze development

Exposure-associated DNA methylation among people exposed to multiple industrial pollutants

Standardizing non-targeted analysis reporting to advance exposure science and environmental epidemiology

ExposomeX: Integrative Exposomic Platform Expediates Discovery of “Exposure-Biology-Disease” Nexus

Automated Cut&run Brings Scalable Epigenomic Profiling to Hematology

High-Resolution Mass Spectrometry for Human Exposomics: Expanding Chemical Space Coverage

Linking high resolution mass spectrometry data with exposure and toxicity forecasts to advance high-throughput environmental monitoring

Use of Exposomic Methods Incorporating Sensors in Environmental Epidemiology

Prospects for incorporation of epigenetic biomarkers in human health and environmental risk assessment of chemicals

Increasing Temporal Sensitivity of Omics Association Studies with Epigenome-Wide Distributed Lag Models

Integrating SNPs-based genetic risk factor with blood epigenomic response of differentially arsenic-exposed rural subjects reveals disease-associated signaling pathways